These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16765261)

  • 41. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae.
    Godzik KL; O'Brien ER; Wang SK; Kuo CC
    J Clin Microbiol; 1995 Sep; 33(9):2411-4. PubMed ID: 7494038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.
    Deniset JF; Pierce GN
    Fundam Clin Pharmacol; 2010 Oct; 24(5):607-17. PubMed ID: 20653790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].
    Stille W; Dittmann R
    Herz; 1998 May; 23(3):185-92. PubMed ID: 9646100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?].
    Fudal M; Wilczewski P
    Wiad Lek; 2004; 57(3-4):151-5. PubMed ID: 15307523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine models of Chlamydia pneumoniae infection and atherosclerosis.
    Moazed TC; Kuo C; Grayston JT; Campbell LA
    J Infect Dis; 1997 Apr; 175(4):883-90. PubMed ID: 9086145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis.
    Coombes BK; Chiu B; Fong IW; Mahony JB
    J Infect Dis; 2002 Jun; 185(11):1621-30. PubMed ID: 12023768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlamydophila pneumoniae. Mechanisms of target cell infection and activation.
    Krüll M; Maass M; Suttorp N; Rupp J
    Thromb Haemost; 2005 Aug; 94(2):319-26. PubMed ID: 16113821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery.
    Yamashita K; Ouchi K; Shirai M; Gondo T; Nakazawa T; Ito H
    Stroke; 1998 Apr; 29(4):773-8. PubMed ID: 9550510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chlamydia pneumoniae-based atherosclerosis: a smoking gun.
    Hoymans VY; Bosmans JM; Ieven MM; Vrints CJ
    Acta Cardiol; 2007 Dec; 62(6):565-71. PubMed ID: 18214121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of Chlamydia pneumoniae in the etiology of atherosclerosis].
    Likhoded VG; Martynova VR
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4 Suppl):117-21. PubMed ID: 12712533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse models of C. pneumoniae infection and atherosclerosis.
    Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.
    Hirono S; Pierce GN
    Mol Cell Biochem; 2003 Apr; 246(1-2):91-5. PubMed ID: 12841348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae.
    Cheng JW; Rivera NG
    Ann Pharmacother; 1998 Dec; 32(12):1310-6. PubMed ID: 9876813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.
    Ramirez JA
    Ann Intern Med; 1996 Dec; 125(12):979-82. PubMed ID: 8967709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chlamydia pneumoniae and atherosclerosis: links to the disease process.
    Byrne GI; Kalayoglu MV
    Am Heart J; 1999 Nov; 138(5 Pt 2):S488-90. PubMed ID: 10539855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice.
    Campbell LA; Moazed TC; Kuo CC; Grayston JT
    Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S23-S32. PubMed ID: 11869267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease.
    Behbahani R; Verme-Gibboney C; Romanelli AM
    Clin Ther; 1999 Aug; 21(8):1286-300; discussion 1285. PubMed ID: 10485501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.